ClinicalTrials.gg
RecruitingNCT04832568Updated Mar 31, 2026

Perioperative EEG-Monitoring and Postoperative Delirium in Patients Undergoing Cardiovascular Surgery

An observational study in Delirium, sponsored by Huazhong University of Science and Technology. Recruiting at 1 site in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-03-31.

Sponsored by Huazhong University of Science and Technology · Observational

How we know

From the registry’s dates

  • Started Jun 2021; still recruiting 5 years 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 96 studies in Delirium with a site in China — 29 open to participants now, 30 under way, none of them phase 3. Delirium · China.

Planned enrollment
19th of 30
200 · median 249
Started
2021
with 8 others
Observational
30 of 96
12 open now
Primary completion
2026-12
later than 16 of 29 live
Registered
50th of 96
by date
Lead sponsor
6 of 96
Huazhong University of Science and Technology

Among the 96 studies in Delirium with a site in China, this one is the 19th largest by planned enrollment of the 30 observational ones that give a count, is one of 9 that started in 2021, is one of 30 observational ones, reaches primary completion later than 16 of the 29 other live ones, and was the 50th registered.

Delirium

935 studies on the registry are indexed under Delirium; 188 are open to participants now.

Browse Delirium studies →

Open to participants now

29 of the 96 studies in Delirium with a site in China are open now. Recruiting first, the newest first:

23 more — sign in →

All 29 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 124 Delirium studies recruiting now, 96 (77%) set no upper age limit and 8 (6%) stop at 75 or younger; 8 take children under 18; 14 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 96 studies in Delirium with a site in China, or all of them as a file.
02

Study summary

Postoperative delirium is common in patients undergoing cardiovascular surgery and associated with poor outcomes. However the pathogenesis of postoperative delirium is poorly understood. Multichannel electroencephalogram is a recognized tool for identifying neurophysiologic states during anesthesia, sleep, and arousal. The aim of the current study is to evaluate the mechanisms and predictors of postoperative delirium in patients undergoing cardiovascular surgery using electroencephalogram.

03

Conditions studied

  • Delirium

Browse trials for

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Patients undergoing cardiovascular surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. age of at least 18 years
  2. normal cognitive function at the time of enrollment evidenced by a (MMSE) score of more than 24 of 30
  3. Chinese Mandarin as the native language
  4. providing

Exclusion criteria

Exclusion Criteria:

  1. pre-existing delirium assessed according to the Confusion Assessment Method (CAM)
  2. history of neurological or psychiatric disease
  3. impaired vision or auditory function which may effect the assessments
  4. unwillingness to participate in the study
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • Delirium is determined by CAM or CAM-ICU score
  • No delirium is determined by CAM or CAM-ICU score
06

What researchers measure

Primary outcomes

  1. Incidence of postoperative delirium

    The incidence of postoperative delirium was determined according to the Confusion Assessment Method (CAM) diagnostic algorithm. The algorithm consists of four clinical criteria: (1) acute onset and fluctuating course, (2) inattention, (3) disorganized thinking, and (4) altered level of consciousness. To define a patient as having delirium, both the first and the second criteria have to be present, as well as either the third or the fourth criteria. The CAM-ICU will be used for patients who are intubated in the postoperative period.

    Time frame: After surgery through to postoperative day 7

Secondary outcomes

  1. Relative power of each brain waves

    Electroencephalogram data were acquired using a 32-channel electroencephalogram recording system (Brain Products, Germany). A 5 min, baseline, eyes-closed recording was conducted at the preoperative holding room when the patient was at rest. Recording of electroencephalogram was commenced before the start of anesthetic induction and was stopped before discharge of the patient from the operating room. We defied delta (1 to 3 Hz), theta (4 to 7 Hz), alpha (8 to 12 Hz), and beta (13 to 40 Hz) frequency bands. And then, the relative power of each frequency bands to the total power of the sum is calculated.

    Time frame: During the stay of the patient in the operating room, after surgery through to postoperative day 7

  2. Duration of delirium

    Time frame: After surgery through to postoperative day 7

  3. Severity of delirium

    Delirium severity is evaluated both as the peak (highest) and sum Confusion Assessment Method - Severity (CAM-S) score over all hospital days. The CAM-S includes two forms: a Short Form (CAM-S Short Form, based on the 4-item algorithm, the sum of score ranging from 0 to 7, with 7 being the most severe) and a Long Form (CAM-S Long Form, based on the 10-item CAM instrument, the sum of score ranging from 0 to 19, with 19 being the most severe).

    Time frame: After surgery through to postoperative day 7

  4. Worst daily pain scores at rest

    Pain scores will be collected three times daily using a numeric rating scale (0, no pain, to 10, worst possible pain).

    Time frame: After surgery through to postoperative day 7

  5. Worst daily pain scores with exertion (deep breathing and cough)

    Pain scores will be collected three times daily using a numeric rating scale (0, no pain, to 10, worst possible pain).

    Time frame: After surgery through to postoperative day 7

  6. Length of stay in the Intensive Care Unit (ICU)

    Measured in days admitted in the ICU

    Time frame: through study completion, an average of 5 days

  7. Length of hospital stay

    Measured in days admitted in the hospital

    Time frame: through study completion, an average of 10 days

Other outcomes

  1. Biomarkers

    Identify biomarkers (such as Ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1), brain-derived neurotrophic factor (BDNF), and metalloproteases-9 (MMP-9) )of delirium and neural damage through changes in circulating plasma proteins and molecules

    Time frame: before and after surgery in operating room, after surgery through to postoperative day 7

07

Study locations

1 of 1 sites recruiting
  • Department of Anaesthesiology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology
    Wuhan, Hubei 430030, China
    Recruiting
    • Hua Zheng, Dr. · Contact
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2021 (actual). Primary completion is estimated for Dec 2026, 66 months after the start.

Of 177 non-industry observational studies under Delirium, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 37. This study's planned 66 months is above that.

Counting every sponsor, half of 179 studies reached it within 20 months; a quarter within 11 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 31, 2021
First posted
Apr 6, 2021
StartActual
Jun 17, 2021
Primary completionEst.
Dec 2026
CompletionEst.
Dec 2027
Last update
Mar 31, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 31, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04832568
Responsible party
Hua Zheng (Principal Investigator, Huazhong University of Science and Technology) — Principal investigator
First posted
Apr 6, 2021
Start date
Jun 17, 2021
Primary completion
Dec 2026 (estimated)
Completion
Dec 2027 (estimated)
Last update
Mar 31, 2026

Study contacts

Hua Zheng, Dr.
Contact
hzheng@hust.edu.cn
0086-27-83663173

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion